Clinical Trial Update: Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients

View source ↗

Summary

An observational study evaluating the effect of ozanimod on fatigue in patients with multiple sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Fatigue, Multiple Sclerosis | Status: TERMINATED